Abstract
Six percent of all cancers occur in men aged 15 to 45 years. Most cancer therapies are cytotoxic and impair spermatogenesis. Sperm cryopreservation remains the cornerstone of fertility preservation for male cancer victims. Recent data suggests that a type of cancer may affect a man's semen quality; however, it is uncertain if various cancers impact post-thaw sperm survival differently. The objective of this study was to characterize sperm parameters from a thawed semen sample from men with different cancers who cryopreserved prior to onco-therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
